sulfasalazine has been researched along with Besnier-Boeck Disease in 2 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mohyuddin, GR | 1 |
| Sultan, F | 1 |
| Zhang, K | 1 |
| Khaleeq, G | 1 |
1 review available for sulfasalazine and Besnier-Boeck Disease
| Article | Year |
|---|---|
Sulfasalazine induced lung toxicity masquerading as sarcoidosis--case report and review of the literature.
Topics: Arthritis, Rheumatoid; Colitis, Ulcerative; Granuloma; Humans; Sarcoidosis; Sulfasalazine | 2013 |
1 other study available for sulfasalazine and Besnier-Boeck Disease
| Article | Year |
|---|---|
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-1993. A 44-year-old man with pulmonary disease and proctitis.
Topics: Adult; Bronchi; Diagnosis, Differential; Eosinophils; Humans; Inflammatory Bowel Diseases; Lung; Mal | 1993 |